Human cell programming company bit.bio closes $25M Series DHuman cell programming company bit.bio has secured $25million in Series D funding to expand its portfolio of human cell models andincrease access to its technology for pharmaceutical companies, biotec...Tech.eu · 2026-11-04T09:01:00.000Z